Cargando...

Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension

Therapies that exploit RNA interference (RNAi) hold great potential for improving disease outcomes. However, there are several challenges that limit the application of RNAi therapeutics. One of the most important challenges is effective delivery of oligonucleotides to target cells and reduced delive...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Control Release
Main Authors: McLendon, Jared M., Joshi, Sachindra R., Sparks, Jeff, Matar, Majed, Fewell, Jason G., Abe, Kohtaro, Oka, Masahiko, McMurtry, Ivan F., Gerthoffer, William T.
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4477514/
https://ncbi.nlm.nih.gov/pubmed/25979327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2015.05.261
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!